ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

House Committee To Examine Personal Genetic Test Kits

May 21, 2010

NCAB Votes To Return P01 Review To Pre-1987 System, Two-Tier Review

May 14, 1993

Medicare Expands Coverage for Lymphedema Pumps.

May 11, 2001

Four More Grants Planned By Prostatic Cancer Project This Year; Applications Still Accepted

August 30, 1974

Breast Cancer Activist, Radiologist Are Added To Special Commission

November 6, 1992

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

February 27, 1981